NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Article in Theranostics (April 2023)

HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma

Article in Cancer Biology & Therapy (December 2022)

αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade

Article in Cancer Immunology, Immunotherapy (October 2022)